Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | CSF1R | P07333 | 5/20 | 0.40 |
| ▸ | EGFR | P00533 | 5/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13367392 | 0.87 | CYP1A2 (0.44) | SIGMAR1CYP1A2MAPTLMNATDP1 | |
| SCHEMBL6283168 | 0.85 | SIGMAR1 (0.43) | SIGMAR1CYP1A2MAPTNR1I2LMNA | |
| SCHEMBL12048720 | 0.84 | TRPM4 (0.41) | SIGMAR1EGFRMAPTLMNATSHR | |
| SCHEMBL12258281 | 0.83 | CYP1A2 (0.40) | CYP1A2MAPTLMNATDP1TSHR | |
| SCHEMBL12048739 | 0.83 | SIGMAR1 (0.50) | SIGMAR1CSF1REGFRCYP1A2MAPT | |
| SCHEMBL13338636 | 0.83 | SIGMAR1 (0.39) | SIGMAR1CSF1REGFRCYP1A2MAPT | |
| SCHEMBL18055161 | 0.83 | SIGMAR1 (0.41) | SIGMAR1CYP1A2MAPTNR1I2LMNA | |
| SCHEMBL13367462 | 0.83 | PDE5A (0.41) | SIGMAR1EGFRCYP1A2PDGFRBKDR | |
| SCHEMBL7800521 | 0.81 | SIGMAR1 (0.40) | SIGMAR1CYP1A2MAPTNR1I2LMNA | |
| SCHEMBL12048256 | 0.80 | CYP1A2 (0.35) | EGFRCYP1A2MAPTLMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OR10J3, OCIAD1, OCIAD2 | SIGMAR1 699/4885CSF1R 2428/4885EGFR 1659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.